A detailed history of Farther Finance Advisors, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 36 shares of HAE stock, worth $2,838. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36
Previous 35 2.86%
Holding current value
$2,838
Previous $2.9 Million 0.1%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$72.45 - $91.58 $72 - $91
1 Added 2.86%
36 $2.89 Million
Q1 2024

May 13, 2024

SELL
$71.24 - $85.35 $356 - $426
-5 Reduced 12.5%
35 $2.97 Million
Q4 2023

Feb 14, 2024

BUY
$80.59 - $92.61 $2,256 - $2,593
28 Added 233.33%
40 $3.42 Million
Q3 2023

Nov 13, 2023

BUY
$82.56 - $93.49 $990 - $1,121
12 New
12 $1.08 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.05B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.